Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Zahra

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Immunology|January 25, 2021
Rapid GMP-Compliant Expansion of SARS-CoV-2-Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19Rachel S Cooper, Alasdair R Fraser, Linda Smith, et al.
Frontiers in Immunology|July 16, 2024
EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulationRachel S Cooper, Catherine Sutherland, Linda M Smith, et al.
Vox Sanguinis|October 26, 2020
Putting the spotlight on donation-related risks and donor safety - are we succeeding in protecting donors?Christina Mikkelsen, Gaia Mori, Suzanna M van Walraven, et al.
BMJ Open|December 9, 2024
Macrophage Therapy for Acute Liver Injury (MAIL): a study protocol for a phase 1 randomised, open-label, dose-escalation study to evaluate safety, tolerability and activity of allogeneic alternatively activated macrophages in patients with paracetamol-induced acute liver injury in the UKChristopher Humphries, Melisande Addison, Guruprasad Aithal, et al.
Vox Sanguinis|November 16, 2020
How donor selection criteria can be evaluated with limited scientific evidence: lessons learned from the TRANSPOSE projectChristina Mikkelsen, Gaia Mori, Suzanna M van Walraven, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Immunology|January 25, 2021
Rapid GMP-Compliant Expansion of SARS-CoV-2-Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19Rachel S Cooper, Alasdair R Fraser, Linda Smith, et al.
Frontiers in Immunology|July 16, 2024
EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulationRachel S Cooper, Catherine Sutherland, Linda M Smith, et al.
Vox Sanguinis|October 26, 2020
Putting the spotlight on donation-related risks and donor safety - are we succeeding in protecting donors?Christina Mikkelsen, Gaia Mori, Suzanna M van Walraven, et al.
BMJ Open|December 9, 2024
Macrophage Therapy for Acute Liver Injury (MAIL): a study protocol for a phase 1 randomised, open-label, dose-escalation study to evaluate safety, tolerability and activity of allogeneic alternatively activated macrophages in patients with paracetamol-induced acute liver injury in the UKChristopher Humphries, Melisande Addison, Guruprasad Aithal, et al.
Vox Sanguinis|November 16, 2020
How donor selection criteria can be evaluated with limited scientific evidence: lessons learned from the TRANSPOSE projectChristina Mikkelsen, Gaia Mori, Suzanna M van Walraven, et al.
Pageof 2